AAAAAA

   
Results: 1-12 |
Results: 12

Authors: WEVER PC VANDERVLIET HJJ SPAENY LHA WOLBINK AM VANDIEPEN FNJ FROELICH CJ HACK CE TENBERGE IJM
Citation: Pc. Wever et al., THE CD8(-CELL SUBSET IN PERIPHERAL-BLOOD FROM HEALTHY-INDIVIDUALS CONTAINS ACTIVATED AND APOPTOSIS-PRONE CELLS() GRANZYME B+ T), Immunology, 93(3), 1998, pp. 383-389

Authors: TENBERGE RJM BUYSMANN S VANDIEPEN FNJ SURACHNO S PALS ST
Citation: Rjm. Tenberge et al., INCREASED EXPRESSION OF ICAM-1 AND VCAM-1 IN THE SKIN AFTER ADMINISTRATION OF THE FIRST DOSE OF OKT3, Transplantation proceedings, 29(1-2), 1997, pp. 325-327

Authors: BUYSMANN S HACK CE VANDIEPEN FNJ SURACHNO J TENBERGE IJM
Citation: S. Buysmann et al., ADMINISTRATION OF OKT3 AS A 2-HOUR INFUSION ATTENUATES FIRST-DOSE SIDE-EFFECTS, Transplantation, 64(11), 1997, pp. 1620-1623

Authors: VANDERVLIET HJJ WEVER PC VANDIEPEN FNJ YONG SL TENBERGE IJM
Citation: Hjj. Vandervliet et al., QUANTIFICATION OF BAX BCL-2 RATIOS IN PERIPHERAL-BLOOD LYMPHOCYTES, MONOCYTES AND GRANULOCYTES AND THEIR RELATION TO SUSCEPTIBILITY TO ANTI-FAS (ANTI-CD95)-INDUCED APOPTOSIS/, Clinical and experimental immunology, 110(2), 1997, pp. 324-328

Authors: BUYSMANN S VANDIEPEN FNJ SURACHNO S PALS ST TENBERGE RJM
Citation: S. Buysmann et al., INCREASED DERMAL EXPRESSION OF ICAM-1 AND VCAM-1 AFTER ADMINISTRATIONOF OKT3 IN MAN, Clinical nephrology, 46(2), 1996, pp. 84-91

Authors: TENBERGE RJM BUYSMANN S VANDIEPEN FNJ SURACHNO S HACK CE
Citation: Rjm. Tenberge et al., CONSEQUENCES OF OKT3 ADMINISTRATION VIA CONTINUOUS-INFUSION AS COMPARED TO BOLUS INFUSION, Transplantation proceedings, 28(6), 1996, pp. 3217-3220

Authors: BUYSMANN S HACK CE VANDIEPEN FNJ WILMINK JM SURACHNO S TENBERGE RJM
Citation: S. Buysmann et al., ADMINISTRATION OF OKT3 VIA CONTINUOUS-INFUSION ATTENUATES FIRST-DOSE SIDE-EFFECTS, Kidney international, 48(4), 1995, pp. 1368-1369

Authors: BEMELMAN FJ BUYSMANN S YONG SL VANDIEPEN FNJ SURACHNO S WILMINK JM SCHELLEKENS PTA TENBERGE RJM
Citation: Fj. Bemelman et al., BIPHASIC GRANULOCYTOPENIA AFTER ADMINISTRATION OF THE FIRST DOSE OF OKT3, Kidney international, 47(4), 1995, pp. 1218-1218

Authors: BUYSMANN S VANDIEPEN FNJ YONG SL SURACHNO S SCHELLEKENS PTA TENBERGE RJM
Citation: S. Buysmann et al., MECHANISM OF LYMPHOCYTOPENIA FOLLOWING ADMINISTRATION OF CORTICOSTEROIDS, Transplantation proceedings, 27(1), 1995, pp. 871-872

Authors: BEMELMAN FJ BUYSMANN S YONG SL VANDIEPEN FNJ SCHELLEKENS PTA TENBERGE RJM
Citation: Fj. Bemelman et al., BIPHASIC GRANULOCYTOPENIA AFTER ADMINISTRATION OF THE FIRST DOSE OF OKT3, The Journal of laboratory and clinical medicine, 126(6), 1995, pp. 571-579

Authors: BUYSMANN S BEMELMAN FJ VANDIEPEN FNJ YONG SL SURACHNO S SCHELLEKENS PTA TENBERGE RJM
Citation: S. Buysmann et al., ADHESION MOLECULES ON PERIPHERAL-BLOOD LYMPHOCYTES FOLLOWING THE FIRST OKT3 ADMINISTRATION, Kidney international, 46(5), 1994, pp. 1468-1468

Authors: BUYSMANN S VANDIEPEN FNJ VANKOOYK Y TENBERGE RJM
Citation: S. Buysmann et al., THE INFLUENCE OF OKT3 ON EXPRESSION OF LYMPHOCYTE ADHESION MOLECULES IN-VITRO, Transplantation proceedings, 26(6), 1994, pp. 3249-3250
Risultati: 1-12 |